Author
Luz Martin
Recent research
- BiologyOpen access
Abstract Background Exome sequencing (ES) has become a key diagnostic tool for rare diseases (RDs). However, most evidence on ES performance comes from high-income countries and patients from European ancestry. In countries such as Chile, limited access to next generation sequenc...